Skip to main content
Clinical Trials/ISRCTN68166254
ISRCTN68166254
Completed
Not Applicable

Detection of pseudoprogression using CT perfusion in patients with Glioblastoma Multiforme post-treatment: an observational cohort study

The Walton Centre NHS Foundation Trust0 sites20 target enrollmentJuly 1, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glioblastoma Multiforme
Sponsor
The Walton Centre NHS Foundation Trust
Enrollment
20
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2015
End Date
March 1, 2016
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with glioblastoma multiforme tumours who will be discussed in the regional neuro\-oncology multidisciplinary team meeting
  • 2\. Patients exhibiting any tumour progression on their first follow\-up imaging immediately after radiotherapy, surgery or chemotherapy post\-treatment without clinical progression

Exclusion Criteria

  • Patients who exhibit tumour progression both clinically (symptoms) and on imaging on the first follow\-up imaging immediately following radiotherapy, chemotherapy or surgery following treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials